BrainEver

BrainEver

BrainEver's platform treats neurodegenerative diseases based on Homeoproteins (HPs). . Learn more

Financials

Estimates*

Edit
  • Edit
DateInvestorsAmountRound

€1.0m

Early VC

€2.5m

Grant

N/A

Early VC
Total Funding€3.5m

Recent News about BrainEver

Edit
More about BrainEver
Edit

Operator of a medical research agency intended to develop drugs for the treatment of neurodegenerative disorders. The company's services specialize in the research and development of novel therapeutics using specific proprietary proteins to treat Parkinson's, amyotrophic lateral sclerosis, and Huntington's diseases, enabling healthcare practitioners to avail of drugs while providing the required treatment efficiently.

Keywords: Pharmaceuticals and Biotechnology, Drug Research Center, Drug Research Process, Homeoprotein Administration, Medical Research Agency, Neurodegenerative Disorder, Novel Therapeutics.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.